DekaBank Deutsche Girozentrale
BNTX icon

DekaBank Deutsche Girozentrale’s BioNTech BNTX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.2M Hold
481,397
– – 0.07% 234
2026
Q1 		$42.1M Hold
481,397
– – 0.07% 234
2025
Q4 		$46.4M Hold
481,397
– – 0.08% 213
2025
Q3 		$47.2M Hold
481,397
– – 0.08% 221
2025
Q2 		$51.8M Buy
481,397
+69,500
+17% +$7.02M 0.09% 206
2025
Q1 		$36.6M Sell
411,897
-69,500
-14% -$7.78M 0.07% 226
2024
Q4 		$54.3M Hold
481,397
– – 0.1% 196
2024
Q3 		$56.9M Buy
481,397
+53,800
+13% +$4.95M 0.11% 194
2024
Q2 		$34.5M Buy
427,597
+15,700
+4% +$1.44M 0.06% 243
2024
Q1 		$38.3M Sell
411,897
-13,174
-3% -$1.26M 0.07% 235
2023
Q4 		$44.6M Buy
425,071
+127,951
+43% +$12.9M 0.09% 217
2023
Q3 		$30.2M Sell
297,120
-16,551
-5% -$1.83M 0.07% 252
2023
Q2 		$33.8M Buy
313,671
+67,315
+27% +$7.57M 0.08% 243
2023
Q1 		$29.7M Sell
246,356
-6,424
-3% -$882K 0.07% 242
2022
Q4 		$38.9M Sell
252,780
-32,159
-11% -$4.95M 0.1% 212
2022
Q3 		$38M Sell
284,939
-36,181
-11% -$5.53M 0.11% 196
2022
Q2 		$46.4M Buy
321,120
+12,085
+4% +$1.85M 0.14% 168
2022
Q1 		$54.1M Buy
309,035
+96,039
+45% +$16.1M 0.13% 167
2021
Q4 		$51.7M Buy
212,996
+34,500
+19% +$9.45M 0.13% 172
2021
Q3 		$50.1M Sell
178,496
-55,181
-24% -$17.5M 0.14% 163
2021
Q2 		$52.8M Sell
233,677
-248,700
-52% -$46.9M 0.15% 160
2021
Q1 		$52.1M Buy
482,377
+348,124
+259% +$37M 0.17% 144
2020
Q4 		$12M Sell
134,253
-110,747
-45% -$10.9M 0.05% 297
2020
Q3 		$16.6M Buy
245,000
+141,200
+136% +$10.1M 0.07% 228
2020
Q2 		$6.87M Buy
103,800
+43,800
+73% +$2.19M 0.04% 266
2020
Q1 		$3.62M Sell
60,000
-217,000
-78% -$8.45M 0.03% 320
2019
Q4 		$9.46M Buy
+277,000
New +$6.21M 0.06% 240

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

DekaBank Deutsche Girozentrale's BNTX Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its BioNTech (BNTX) position steady in Q2 2026 at 481,397 shares worth $41.2M. The position accounts for 0.07% of the portfolio, ranked #234.

DekaBank Deutsche Girozentrale first reported a position in BNTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $56.9M in Q3 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 481,397 shares of BioNTech worth $41.2M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up 0.07% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #234 holding.
  • DekaBank Deutsche Girozentrale first reported a position in BioNTech in Q4 2019 and has held it in 27 quarters since.
  • DekaBank Deutsche Girozentrale's BioNTech position peaked at $56.9M in Q3 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.